Coronary artery ectasia: remains a clinical dilemma
Usama Boles1, Peter Eriksson, Ying Zhao
1Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Coronary Artery Disease
|July 10, 2010
Summary
Coronary artery ectasia (CAE) involves abnormal widening of coronary arteries. This review examines CAE
Area of Science:
- Cardiology
- Vascular Medicine
- Medical Research
Background:
- Coronary artery ectasia (CAE) is defined by a localized dilatation of coronary arteries.
- Its incidence ranges from 1.5% to 10%, varying by region.
- Atherosclerosis is a primary association in Western populations, while Kawasaki disease is a significant cause in children.
Purpose of the Study:
- To review coronary artery ectasia (CAE).
- To explore its prevalence, pathogenesis, and diagnostic approaches.
- To discuss its relationship with other vascular anomalies.
Main Methods:
- Literature review of existing studies on coronary artery ectasia.
- Analysis of epidemiological data and etiological factors.
- Evaluation of current diagnostic modalities and biomarker research.
Main Results:
- CAE prevalence varies significantly worldwide.
- Pathogenesis is multifactorial, with atherosclerosis and Kawasaki disease as key contributors.
- Biomarker studies for CAE activity are complicated by its frequent association with atherosclerosis.
Conclusions:
- Coronary artery ectasia is a complex condition with diverse etiologies.
- Further research is needed to fully elucidate its pathogenesis and improve diagnostic accuracy.
- Understanding CAE's relationship with systemic vascular anomalies is crucial for comprehensive patient care.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...